当前位置:
X-MOL 学术
›
Arthritis Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2024-09-22 , DOI: 10.1002/art.43014 Anna Eberhard, Daniela Di Giuseppe, Johan Askling, Stefan Bergman, Hannah Bower, Katerina Chatzidionysiou, Helena Forsblad-d'Elia, Alf Kastbom, Tor Olofsson, Thomas Frisell, Carl Turesson
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2024-09-22 , DOI: 10.1002/art.43014 Anna Eberhard, Daniela Di Giuseppe, Johan Askling, Stefan Bergman, Hannah Bower, Katerina Chatzidionysiou, Helena Forsblad-d'Elia, Alf Kastbom, Tor Olofsson, Thomas Frisell, Carl Turesson
To compare the effectiveness of JAK inhibitors (JAKis) and biologic disease-modifying antirheumatic drugs (bDMARDs) on pain in patients with rheumatoid arthritis.
中文翻译:
JAK 抑制剂与生物疾病缓解抗风湿药相比对类风湿性关节炎疼痛减轻的有效性:瑞典一项全国队列研究的结果
比较 JAK 抑制剂 (JAKis) 和生物疾病缓解抗风湿药 (bDMARDs) 对类风湿性关节炎患者疼痛的疗效。
更新日期:2024-09-22
中文翻译:
JAK 抑制剂与生物疾病缓解抗风湿药相比对类风湿性关节炎疼痛减轻的有效性:瑞典一项全国队列研究的结果
比较 JAK 抑制剂 (JAKis) 和生物疾病缓解抗风湿药 (bDMARDs) 对类风湿性关节炎患者疼痛的疗效。